- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783832298746
- Maße
-
21 cm, 275 g
- Umfang
-
IV, VI, 171 S.
- Sprache
-
Englisch
- Anmerkungen
-
Ill., graph. Darst.
Zugl.: Hamburg, Univ., Diss., 2010
- Schlagwort
-
Arzneimittelentwicklung
Screening
Computational chemistry
Indizierung
Moleküldeskriptor
Physikalisch-chemische Eigenschaft
Moleküldeskriptor
Computational chemistry
Physikalisch-chemische Eigenschaft
Screening
Arzneimittelentwicklung
Indizierung (Informatik)
Computersimulation
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Schlosser, Jochen
- Shaker
Entstanden
- 2011
Ähnliche Objekte (12)
Structure-Based Virtual Screening Using Index Technology
Analysis of ligand- and structure-based virtual screening data
Towards Effective Consensus Scoring in Structure-Based Virtual Screening
Identification of Plk1 type II inhibitors by structure-based virtual screening
Discovery of Tyrosinase Inhibitors: Structure-Based Virtual Screening and Biological Evaluation
Comprehensive machine learning boosts structure-based virtual screening for PARP1 inhibitors
Utilizing a structure-based virtual screening approach to discover potential LSD1 inhibitors
Structural analysis of 20S proteasome and development of structure-based virtual screening methods
Structural Analysis of 20S Proteasome and Development of Structure-Based Virtual Screening Methods
Structure-based substrate screening for an enzyme
Evaluation of the performance of 3D virtual screening programs: docking vs. structure-based pharmacophore
Computational virtual screening and structure-based design of some epidermal growth factor receptor inhibitors
Structure-Based Virtual Screening Using Index Technology
Analysis of ligand- and structure-based virtual screening data
Towards Effective Consensus Scoring in Structure-Based Virtual Screening
Identification of Plk1 type II inhibitors by structure-based virtual screening
Discovery of Tyrosinase Inhibitors: Structure-Based Virtual Screening and Biological Evaluation
Comprehensive machine learning boosts structure-based virtual screening for PARP1 inhibitors
Utilizing a structure-based virtual screening approach to discover potential LSD1 inhibitors
Structural analysis of 20S proteasome and development of structure-based virtual screening methods
Structural Analysis of 20S Proteasome and Development of Structure-Based Virtual Screening Methods
Structure-based substrate screening for an enzyme
Evaluation of the performance of 3D virtual screening programs: docking vs. structure-based pharmacophore
Computational virtual screening and structure-based design of some epidermal growth factor receptor inhibitors
Structure-Based Virtual Screening Using Index Technology
Analysis of ligand- and structure-based virtual screening data
Towards Effective Consensus Scoring in Structure-Based Virtual Screening
Identification of Plk1 type II inhibitors by structure-based virtual screening
Discovery of Tyrosinase Inhibitors: Structure-Based Virtual Screening and Biological Evaluation
Comprehensive machine learning boosts structure-based virtual screening for PARP1 inhibitors
Utilizing a structure-based virtual screening approach to discover potential LSD1 inhibitors
Structural analysis of 20S proteasome and development of structure-based virtual screening methods
Structural Analysis of 20S Proteasome and Development of Structure-Based Virtual Screening Methods
Structure-based substrate screening for an enzyme
Evaluation of the performance of 3D virtual screening programs: docking vs. structure-based pharmacophore